Stock comparison
CONMED
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
CNMD
CONMED
Market cap
$1.12B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | CNMD | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 45D | 69B | MTD |
| Benjamin Graham | 36D | 65B | MTD |
| Philip Fisher | 34F | 63C | MTD |
| Peter Lynch | 21F | 66B | MTD |
| Joel Greenblatt | 24F | 68B | MTD |
| Charlie Munger | 41D | 74B | MTD |
| Terry Smith | 36D | 70B | MTD |
Side-by-side metrics
| Metric | CNMD | MTD |
|---|---|---|
| Market cap | $1.12B | $22.29B |
| P/E (TTM) | 19.6x | 25.3x |
| EV/EBIT | 13.4x | 21.6x |
| ROIC (TTM) | 5.08% | 36.09% |
| Gross margin | 53.58% | 57.79% |
| Net margin | 4.0% | 21.4% |
| Revenue CAGR 5y | 7.99% | 2.01% |
| EPS CAGR 5y | -8.2% | 6.12% |
| Debt / Equity | 0.8x | - |
| Dividend yield | 1.14% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CNMD leads on
- Dividend yield1.14%vs 0.0%+100%
- Revenue CAGR 5y7.99%vs 2.01%+75%
- EV/EBIT13.4xvs 21.6x+38%
- P/E (TTM)19.6xvs 25.3x+22%
MTD leads on
- EPS CAGR 5y6.12%vs -8.2%+175%
- Debt / Equity-vs 0.8x+102%
- Market cap$22.29Bvs $1.12B+95%
- ROIC (TTM)36.09%vs 5.08%+86%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.